Validation of tissue microarray technology in endometrioid cancer of the endometrium

Journal of Clinical Pathology

Volumn 60, Issue 5, 2007, Pages 500-503

  Fons, Guus ^a   Hasibuan, Siti M ^b   Van Der Velden, Jacobus ^a   Ten Kate, Fiebo J W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Anatomical Pathology   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY; TUMOR BIOPSY; VALIDATION STUDY;

BIOPSY; CA-15-3 ANTIGEN; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249866188     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.040170     Document Type: Article

References (11)

1. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
2. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
3. Dawson B, Trapp RG. Basic and Clinical Biostatistics. New York: Lange Medical Books/McGraw-Hill, 2004.
4. Gulmann C, Butler D, Kay E, Grace A, Leader M. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 2003;42:70-6.
5. Nocito A, Bubendorf L, Maria TE, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AG, Flury R, Jager P, Luc FJ, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-57.
6. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245- 51.
7. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 1998;29:924-31.
8. Bergeron C, Ferenczy A, Toft DO, Shyamala G. Immunocytochemical study of progesterone receptors in hyperplastic and neoplastic endometrial tissues. Cancer Res 1988;48:6132-6.
9. Zaino RJ, Clarke CL, Mortel R, Satyaswaroop PG. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 1988;48:1889-95.
10. Morse AR, Curran GJ. Distribution of epithelial membrane antigen in normal and abnormal endometrial tissue. Br J Obstet Gynaecol 1985;92:1286-90.
11. Coronado PJ, Fasero M, Vidart JA, Puerta J, Magrina J, Furio-Bacete V, Escudero M. A comparison of epithelial membrane antigen overexpression in benign and malignant endometrium. Gynecol Oncol 2001;82:483-8.